YOLFTbeta
00

Jiangsu Sihuan Bioengineering Co Ltd

000518 · SHE · Healthcare / Biotechnology

3.01CNY-0.09 (-2.90%)

Price History

Full chart

Market Stats

Previous Close3.10
Open3.10
Day Range2.99 – 3.11
52-Week Range2.28 – 4.54
Volume16.45M
Market Cap3.70B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.05
Dividend Yield0.00%
Beta0.29
50-Day Avg3.81
200-Day Avg3.20

About

Jiangsu Sihuan Bioengineering Co., Ltd., together with its subsidiaries, engages in the production and sales of biopharmaceutical products in China and internationally. The company offers Delusen and New Delusen, a human interleukin-2 for injection are immunomodulators used for the biotherapy of tumors and treatment of patients with weakened immune function; Xinlisheng, a human granulocyte colony-stimulating factor injection used to treat neutropenia caused by bone marrow transplantation, cancer chemotherapy, myelodysplastic syndrome, and aplastic anemia; and Huanerbo, a human erythropoietin injection used to treat symptoms, such as anemia caused by renal insufficiency. It is also involved in the provision of flower planting; forest and natural ecosystem management and protection; forest improvement; forestry product sales; Chinese herbal medicine planting; landscaping project construction; urban municipal greening management; scenic area management; municipal facilities management; earthwork construction; engineering management services; forest park management and design management; external contracting; project cost consulting services; and sale of metal material, agricultural and sideline product, and building and decoration material. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Long Chen
  • Employees232
  • HeadquartersNo. 2 Binjiang East Road, Jiangyin, China, 214434, China
  • Websitehttps://www.000518shsw.com

Leadership

  • Mr. Long ChenGM & Non-independent Director · b. 1988
  • Mr. Linfu WeiDeputy GM & Non-independent director · b. 1988
  • Mr. Yang ZhouDeputy GM & Board Secretary · b. 1985
  • Mr. Xiaofeng LiuDeputy General Manager · b. 1965
  • Ms. Haizhen XuAccounting Supervisor · b. 1978

Financials

Income Statement

Currency: CNY1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue75.91M73.63M62.34M82.02M59.16M83.53M206.71M507.79K105.25M187.25M366.76M470.08M375.66M311.48M205.74M281.08M281.29M179.41M194.08M208.37M244.14M262.47M208.75M241.23M237.84M327.31M346.05M395.51M417.88M505.40M350.96M270.15M235.42M203.52M344.38M
Growth (%)--3.00%-15.34%+31.58%-27.87%+41.18%+147.47%-99.75%+20626.40%+77.91%+95.87%+28.17%-20.08%-17.08%-33.95%+36.62%+0.07%-36.22%+8.18%+7.36%+17.17%+7.51%-20.47%+15.56%-1.40%+37.62%+5.73%+14.29%+5.65%+20.94%-30.56%-23.03%-12.86%-13.55%+69.22%
Cost of Revenue--53.76M73.44M60.79M94.46M186.45M691.52K73.74M120.69M239.58M330.30M243.22M221.73M171.17M201.63M236.15M179.60M111.53M110.56M126.61M137.57M109.38M104.22M109.77M114.32M97.11M110.29M114.08M203.18M115.11M86.36M88.08M113.41M215.92M
Gross Profit75.91M73.63M8.57M8.58M-1.62M-10.93M20.26M-183.73K31.51M66.55M127.18M139.78M132.45M89.75M34.57M79.45M45.13M-186.12K82.55M97.81M117.53M124.90M99.37M137.02M128.08M212.99M248.95M285.23M303.80M302.22M235.85M183.79M147.34M90.11M128.46M
Gross Margin100.00%100.00%13.76%10.46%-2.75%-13.09%9.80%-36.18%29.94%35.54%34.68%29.73%35.26%28.81%16.80%28.27%16.05%-0.10%42.53%46.94%48.14%47.59%47.60%56.80%53.85%65.07%71.94%72.12%72.70%59.80%67.20%68.03%62.59%44.27%37.30%
Operating Expense00-15.52M-10.71M12.54M16.86M6.35M25.68M5.39M10.50M31.38M26.54M35.53M69.51M87.66M67.97M160.25M150.23M59.04M91.38M114.28M103.92M190.63M135.68M236.73M214.07M230.44M314.03M275.74M262.37M271.31M237.94M223.89M168.96M158.63M
Operating Income75.91M73.63M24.10M19.29M-14.17M-27.80M13.90M-25.86M26.12M56.06M95.80M113.24M96.91M20.24M-53.09M11.48M-115.12M-150.42M23.51M6.43M3.25M20.98M-91.26M1.33M-108.65M-1.08M18.50M-28.81M28.07M39.85M-35.46M-54.16M-76.55M-78.86M-30.17M
Operating Margin100.00%100.00%38.66%23.52%-23.95%-33.28%6.73%-5093.12%24.82%29.94%26.12%24.09%25.80%6.50%-25.81%4.08%-40.93%-83.84%12.12%3.09%1.33%7.99%-43.72%0.55%-45.68%-0.33%5.35%-7.28%6.72%7.88%-10.10%-20.05%-32.52%-38.75%-8.76%
EBITDA75.91M73.63M3.75M1.74M-11.69M-26.57M-27.39M-14.04M21.52M60.74M105.84M142.16M128.88M58.37M-52.71M52.98M-133.64M-111.02M50.25M32.85M37.94M49.01M-62.27M27.12M-65.65M52.79M37.81M-10.25M50.59M55.65M-14.62M-31.96M-57.67M-97.85M-21.16M
EBITDA Margin100.00%100.00%6.02%2.12%-19.75%-31.81%-13.25%-2765.71%20.44%32.44%28.86%30.24%34.31%18.74%-25.62%18.85%-47.51%-61.88%25.89%15.77%15.54%18.67%-29.83%11.24%-27.60%16.13%10.93%-2.59%12.11%11.01%-4.17%-11.83%-24.50%-48.08%-6.14%
Net Income3.81M6.43M20.42M18.42M-14.29M-28.63M5.79M-31.24M38.72M53.02M76.38M85.69M68.97M11.22M-103.54M7.16M-176.84M-139.87M23.34M7.65M-5.96M10.07M-70.71M5.96M-74.45M4.47M7.29M-29.44M14.33M27.30M-34.79M-48.79M-75.27M-109.99M-37.09M
Net Income Margin5.03%8.74%32.76%22.45%-24.16%-34.27%2.80%-6152.86%36.79%28.31%20.83%18.23%18.36%3.60%-50.33%2.55%-62.87%-77.96%12.03%3.67%-2.44%3.84%-33.88%2.47%-31.30%1.37%2.11%-7.44%3.43%5.40%-9.91%-18.06%-31.97%-54.05%-10.77%
R&D-------------------6.16M3.23M7.66M7.60M10.49M12.28M10.47M8.58M12.58M42.98M40.70M51.84M38.97M29.15M29.01M32.48M
R&D as % of Total Revenue-------------------2.96%1.32%2.92%3.64%4.35%5.16%3.20%2.48%3.18%10.29%8.05%14.77%14.42%12.38%14.25%9.43%
Interest Expense-----2.22M-3.33M2.37M1.18M2.44M2.00M1.62M6.24M4.65M3.47M3.62M111.40K2.06M18.40K40.55K95.21K6.10M4.45M5.92M13.34M1.94M2.95M3.77M814.11K2.66M2.00M2.51M2.14M1.69M
Interest Expense % of Total Revenue-----2.65%-654.85%2.25%0.63%0.66%0.43%0.43%2.00%2.26%1.23%1.29%0.06%1.06%0.01%0.02%0.04%2.92%1.85%2.49%4.07%0.56%0.74%0.90%0.16%0.76%0.74%1.06%1.05%0.49%

Balance Sheet

Currency: CNY1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-126.97M254.61M283.19M261.39M273.91M299.24M180.33M216.71M274.67M1.08B1.14B1.23B1.39B1.30B1.23B883.26M776.07M752.69M962.04M969.94M912.85M822.58M818.08M834.53M1.02B931.63M925.88M915.83M823.71M799.31M738.08M660.98M567.40M494.04M
Total Liabilities-59.40M43.88M54.59M52.42M93.36M109.29M76.03M59.88M69.84M98.90M82.39M134.53M282.43M292.56M217.36M49.50M83.21M40.32M82.32M54.17M82.61M91.81M96.49M225.84M406.26M256.08M283.07M255.51M138.66M152.54M144.58M148.19M168.43M134.68M
Total Equity-67.57M208.37M226.78M208.96M179.00M185.79M104.29M156.83M204.83M980.01M1.06B1.09B1.10B999.76M1.00B828.91M689.04M712.38M716.40M710.44M745.82M675.11M681.07M606.62M611.10M628.64M599.20M613.53M640.82M606.03M557.24M481.71M371.71M334.62M
Cash-1.72M20.58M25.13M4.36M11.28M10.71M729.48K7.93M26.58M298.11M352.44M395.20M387.51M306.30M193.86M75.01M64.70M71.41M134.58M200.82M196.14M139.76M34.75M24.09M64.95M40.73M39.43M53.08M54.59M38.11M28.18M18.93M8.01M89.55M
Total Debt-42.23M31.62M28.31M28.50M37.22M31.20M26.20M24.30M25.95M3.35M3.35M52.05M92.05M141.65M132.05M2.05M51.75M1.75M---11.21M1.66M35.00M53.00M50.00M70.00M16.02M16.02M51.10M48.75M42.49M30.64M-
Net Debt-40.51M11.04M3.17M24.14M25.94M20.49M25.47M16.37M-634.82K-294.76M-349.09M-343.15M-295.46M-164.65M-61.81M-72.96M-12.95M-69.66M-134.58M-200.82M-196.14M-128.55M-33.09M10.91M-11.95M9.27M30.57M-37.06M-38.58M12.99M20.57M23.56M22.63M-

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-4.37M3.44M23.56M29.40M171.92M82.91M54.05M-5.42M-37.26M26.92M68.69M57.00M231.62M20.07M54.56M-19.02M20.09M-136.11M11.58M-10.79M22.57M58.63M100.23M155.65K4.87M1.63M1.46M78.12M
Investing Cash Flow4.25M4.74M-6.03M-440.07M-113.10M-54.17M-94.03M-121.77M-28.60M-11.42M-127.05M142.87M-155.25M46.17M-59.25M-61.46M-123.68M96.67M9.34M28.88M-7.27M-15.14M-7.95M-9.18M-8.47M-8.49M2.63M-
Financing Cash Flow-1.84M-976.89K1.12M682.20M-4.49M14.01M32.29M-43.95M23.42M-104.35M48.08M-193.16M--023.97M-8.42M31.48M24.20M-42.27M-16.71M-29.53M-90.50M-7.70M-6.57M-5.61M-11.33M-
Capital Expenditure0012.22M95.54M109.57M54.39M103.44M117.24M35.33M18.82M13.76M6.09M11.23M39.74M62.40M15.82M111.04M30.27M19.20M24.13M6.07M15.19M8.70M7.69M8.47M8.19M5.56M3.60M
Free Cash Flow-4.37M3.44M11.34M-66.14M62.34M28.53M-49.39M-122.66M-72.59M8.10M54.93M50.90M220.40M-19.67M-7.83M-34.84M-90.95M-166.39M-7.62M-34.92M16.49M43.44M91.53M-7.53M-3.61M-6.56M-4.10M74.52M
Dividends Paid1.84M876.89K85.48K6.77M4.49M34.69M7.71M3.75M3.57M4.35M1.92M14.73M---916.55K487.30K1.87M1.98M11.79M2.70M3.50M540.90K703.93K717.48K766.28K600.35K575.20K
FCF to OCF100.00%100.00%48.13%-224.97%36.26%34.41%-91.37%2262.68%194.83%30.09%79.97%89.31%95.15%-98.02%-14.36%183.21%-452.73%122.24%-65.83%323.72%73.08%74.09%91.32%-4838.27%-74.17%-402.82%-280.53%95.40%
Dividend Paid to FCF-42.15%25.49%0.75%-10.23%7.20%121.61%-15.61%-3.06%-4.91%53.71%3.49%28.93%----2.63%-0.54%-1.12%-26.00%-33.77%16.35%8.06%0.59%-9.35%-19.88%-11.67%-14.64%0.77%

Earnings

Report DateMar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 25, 2020Aug 29, 2020Oct 30, 2020Dec 31, 2020Apr 30, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 21, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 21, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------------------------
EPS Actual-0.02-0.01-0.01-0.140.000.000.00-0.140.00-0.000.000.020.000.000.000.000.000.000.00-0.010.000.000.000.01-0.000.000.00-0.070.010.010.01-0.020.01-0.01-0.01-0.07-0.00-0.000.01-0.010.010.010.01-0.030.00-0.00-0.01-0.02-0.010.000.020.000.01-0.000.010.01-0.01-0.010.00-0.01-0.02-0.01-0.00-0.01-0.02-0.02-0.01-0.03-0.00-0.01-0.00-0.09-0.020.01-0.00-0.02-0.01-0.01
Surprise------------------------------------------------------------------------------
Timing--------------------------------------------------------------------After-hours---After-hours-----

Key Statistics & Ratios

Market Cap3.70B
Enterprise Value3.76B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales13.53
Price / Book12.27
EPS-0.05
Book Value0.30
Revenue (TTM)273.23M
Gross Profit (TTM)82.81M
EBITDA-49.89M
Profit Margin-19.33%
Operating Margin-53.18%
Return on Equity-16.03%
Return on Assets-7.70%
Shares Outstanding1.03B
Shares Float620.94M
Beta0.29
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20032×
0.03Aug 26, 20030.01Jul 22, 2003
20021×
0.00Mar 20, 2002
20011×
0.01Apr 20, 2001
19961×
0.00Jul 30, 1996
19951×
0.00Aug 30, 1995

Stock Splits

  • Aug 26, 20032:1
  • Aug 29, 20021.8:1
  • Mar 20, 200216:10
  • Aug 30, 199511:10
  • Jun 3, 19941.2:1